TRIB3 and central nervous system cancer: In fact, this is logical in the context of our analysis, as the hypoxia-upregulated U87-MG-specific miR-26b-5p (as it was mentioned a “general suppressor”) can potentially inhibit TRIB3 activity (“glioma oncogene”) in a ceRNA manner.